Pollen Allergy Therapeutic Pipeline Review and Market Analysis 2015

‘Pollen Allergy – Pipeline Review, H1 2015′, provides an overview of the Pollen Allergy’s therapeutic pipeline. Pollen allergy is an allergic response to pollen from trees and grasses. The symptoms of pollen allergies include sneezing, swollen eyelids and itchy eyes, coughing, wheezing and trouble breathing. This skin test cannot classify all allergies, however it does cover major categories, such as common respiratory allergies, penicillin, food, and insect stings.

Order a Purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=356476 . (This is a premium report Price at US$2000 for a single user License)

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

This report provides comprehensive information on the therapeutic development for Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pollen Allergy and special features on late-stage and discontinued projects.

Explore more reports on Pharmaceuticals at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals .

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of...